Wall Street is not afraid of the Federal Reserve's "hawkish interest rate cuts"; will the "Christmas rally" in the U.S. stock market arrive as scheduled?
Wall Street analysts are not overly concerned and believe that Wednesday's sell-off presents a good buying opportunity, and a strong reaction to the Federal Reserve meeting is unlikely to disrupt this year's 'Santa Claus rally' momentum.
FDA Rejects Lexicon's Zynquista for Diabetes, Kidney Disease
Peoples Bancorp Agrees to Sell Its Assets, Liabilities to Hanscom Federal Credit Union
Analyst Expectations For Chart Industries's Future
Lexicon Receives Complete Response Letter for Zynquista; Says This Expected Communication From The FDA Aligns With Previously Disclosed Strategic Decision To Discontinue Launch Preparations For Zynquista And Focus Solely On Its Clinical Development...
Fennec's Pedmarqsi Gets Nod From U.K. Regulators
National Healthcare Properties Announces Ticker Symbol Change From "HTIA" And "HTIBP" To "NHPAP" And "NHPBP"
Fed Cuts Interest Rates, But Powell Spoils Santa Claus Rally; Dollar Surges To Over 2-Year High, Bitcoin Sinks Below $100,000: This Week In The Market
11 Communication Services Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
Billionaire John Paulson Bullish On Gold Miners, Including This Penny Stock
Deep Dive Into Old National Stock: Analyst Perspectives (7 Ratings)
Rhythm Gets FDA Approval for Imcivree for Toddlers
Demystifying Virtus Inv: Insights From 4 Analyst Reviews
Benzinga Market Summary: S&P Rises On PCE Data, Novo Nordisk Falls On Weight Loss Data, Diabetes Stocks Rise
EXCLUSIVE: SoundHound AI CEO On 882% Growth — 'We're Just Getting Started'
Options Corner: Extract Quick Yield Off Beyond Meat's Volatility With Bear Call Spreads
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet, Including QUBT, QBTS
Globalstar Shares Are Trading Higher Following Stock Purchases by a Company Director.
Tandem Diabetes Care Shares Are Trading Higher Amid Strength in Diabetes-related Stocks Following Weight Loss Data From Novo Nordisk.